Skip to main content
. 2009 Aug 12;32(11):2005–2009. doi: 10.2337/dc09-0656

Table 3.

Fetal and neonatal complications in type 1 diabetic pregnancies and the general obstetric population

Outcome variable Proportions (% if not indicated otherwise)
OR (95% CI) for group differences
Type 1 diabetes Control Crude Adjusted
Stillbirth 1.5 0.3 4.04 (3.02–5.40) 3.34 (2.46–4.55)
Fetal distress 14 6.2 2.45 (2.24–2.69) 2.34 (2.12–2.58)
Perinatal mortality (‰) 20 4.8 4.02 (3.11–5.20) 3.29 (2.50–4.33)
Neonatal mortality, 0–7 days (‰) 5.1 1.8 2.91 (1.97–4.28) 3.05 (1.68–5.55)
Neonatal mortality, 0–28 days (‰) 7.0 2.2 3.08 (2.02–4.70) 2.67 (1.72–4.16)
Birth <37 weeks gestational age 21 5.1 5.27 (4.88–5.71) 4.86 (4.47–5.28)
Birth <32 weeks gestational age 2.3 0.7 3.58 (2.89–4.44) 3.08 (2.45–3.87)
LGA 31 3.6 12.2 (11.4–13.1) 11.4 (10.6–12.4)
SGA 2.3 2.5 0.80 (0.63–1.02) 0.71 (0.55–0.91)
Major malformations 4.7 1.8 2.70 (2.37–3.08) 2.50 (2.13–2.94)
Apgar score <7 at 5 min 3.1 1.1 2.98 (2.54–3.50) 2.60 (2.14–3.17)
Apgar score <4 at 5 min 0.80 0.30 2.60 (1.79–3.78) 2.39 (1.64–3.51)
Erb palsy* 2.1 0.25 7.91 (5.77–10.8) 6.69 (4.81–9.31)
Respiratory distress syndrome 1.0 0.20 4.88 (3.51–6.81) 4.65 (2.20–9.84)
Respiratory disorders 9.5 2.6 4.02 (3.67–4.42) 3.42 (3.04–3.85)

Data are proportions or OR (95% CI). Adjusted OR, OR adjusted for group differences in maternal age, BMI, parity, chronic hypertensive disorder, smoking habits, and ethnicity.

*Vaginal deliveries only.